medigraphic.com
ISSN 1527-3172 (Electronic)

2015, Number 1

<< Back Next >>

MEDICC Review 2015; 17 (1)

Lung cancer diagnostic delay in a Havana hospital

Fernández VLJF, Pérez CH, Samper NJA

Language: English
References: 30
Page: 55-57
PDF size: 99.32 Kb.


ABSTRACT

INTRODUCTION Lung cancer is one of the leading causes of death worldwide and in Cuba, where its incidence and mortality are on the rise. Diagnostic delay is a variable linked to survival and prognosis. Quantifying this delay and comparing it with data from other national and international sources may lead to planning actions to reduce its impact.
OBJECTIVES Assess diagnostic delay of lung cancer in patients at the Joaquín Albarrán Clinical-Surgical Teaching Hospital, Havana, Cuba, from 2007 to 2010.
METHODS A retrospective descriptive study was conducted based on administrative data from patients diagnosed with lung cancer. The length of overall diagnostic delay was determined, as well delay between symptom onset and the patient's first contact with the health system, and delay at the primary and secondary levels of the national health system. Descriptive statistics were used to summarize the different time intervals.
RESULTS The study comprised a total of 54 patients; 74.1% were men; the largest age group was 51–60 years. Of the total, 61.1% sought care first at the primary level. Total diagnostic delay for these patients was 67.4 days: 24.3 days due to patient delay (SD 32.8), 16.2 days due to primary care delay (SD 5.2), and 26.9 days due to secondary care delay (SD 20.1). The total delay for patients first seen at the secondary care level was 79.1 days (SD 81.8): 47.8 days due to patient delay (SD 25.6), and 31.3 days due to secondary level delay (SD 14.4).
CONCLUSIONS Diagnostic delay in lung cancer is high. Patients who went directly to hospital did not benefit from shorter delay in diagnosis.


REFERENCES

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013 Jan;63(1):11–30.

  2. Domínguez Alonso E, Seuc JA, Galán Y. Años de vida saludable perdidos por cáncer de pulmón en Cuba en años seleccionados. Rev Cubana Salud Pública [Internet]. 2011 [cited 2013 Dec 26];37(4):428 –41. Available from: http://www .bvs.sld.cu/revistas/spu/vol_37_04_11/spu07411 .htm. Spanish.

  3. Center for Population and Development Studies (CU). Anuario Demográfi co de Cuba 2012. Havana: National Statistics Bureau (CU); 2012. Spanish.

  4. Duménigo Arias O, De Armas Pérez B, Gil Hernández A, Gordis Aguilera MV. Nódulo pulmonar solitario: ¿Qué hacer? Rev Cubana Cir [Internet]. 2007 Apr–Jun [cited 2013 Nov 26];46(2). Available from: http://scielo.sld.cu/scie lo.php?script=sci_arttext&pid=S0034749320070 00200009&lng=es&nrm=iso. Spanish.

  5. Sánchez De Cos Escuín J. El cáncer de pulmón en España. Epidemiología, supervivencia y tratamiento actuales. Arch Bronconeumol. 2009 Jul;45(7):341–8. Spanish.

  6. Ellis PM, Vandermeer R. Delays in the diagnosis of lung cancer. J Thorac Dis. 2011 Sep;3(3):183–8.

  7. Rivera C, Mathiaux J, Haaser T, Begueret H, Jougon J, Trouette R. [Delays in the diagnosis and treatment of lung cancer for patients treated with radiation therapy]. Bull Cancer. 2012 Dec;99(12):1117–22. French.

  8. Chandra S, Mohan A, Guleria R, Singh V, Yadav P. Delays during the diagnostic evaluation and treatment of lung cancer. Asian Pac J Cancer Prev. 2009 Jul–Sep;10(3):453–6.

  9. Almádana Pacheco V, Vázquez Martín M, Sánchez Varilla JM, Torres Gómez J, Dante García H, Martínez Fuentes V. Demora desde el diagnóstico hasta el tratamiento quirúrgico en el cáncer de pulmón en el área hospitalaria virgen Macarena de Sevilla. An Med Interna (Madrid). 2005 Aug;22(8):361–3. Spanish.

  10. Lima Guerra A, Gassiot Nuño C, Ramos Quevedo A, Rodríguez Vázquez JC, Cabanes Varona L, Morales Sánchez L, et al. Conducta diagnóstica y pronóstico en pacientes con carcinoma pulmonar de células no pequeñas en estadios quirúrgicos. Rev Cub Med. 2012 Jan– Mar;51(1):15–24. Spanish.

  11. Valdés Díaz S, García Silvera E, Pérez Cruz H. Length of diagnostic delay in patients with nonsmall- cell lung cancer. MEDICC Rev. 2010 Winter; 12(1):29–32.

  12. Borrego Díaz L, González Sapsin K, Borrego Pino L, Dovale Borjas B, González Sapsin K. Diagnóstico tardío del cáncer en adultos mayores. Correo Científi co Médico de Holguín. 2008;12(5):1–8. Spanish.

  13. Radzikowska E, Roszkowski-Śliż K, Głaz P. The impact of timeliness of care on survival in non-small cell lung cancer patients. Pneumonol Alergol Pol. 2012;80(5):422–9.

  14. Sulu E, Tasolar O, Berk Takir H, Yagci Tuncer L, Karakurt Z, Yilmaz A. Delays in the diagnosis and treatment of non-small-cell lung cancer. Tumori. 2011 Nov–Dec;97(6):693–7.

  15. Allgar VL, Neal RD. Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer. Br J Cancer. 2005 Jun 6;92(11):1959–70.

  16. Baughan P, O’Neill B, Fletcher E. Auditing the diagnosis of cancer in primary care: the experience in Scotland. Br J Cancer. 2009 Dec 3;101 Suppl 2:S87–91.

  17. Hueto Pérez De Heredia J, Cebollero Rivas P, Cascante Rodrigo JA, Andrade Vela I, Pascal Martínez I, Boldú Mitjans J, et al. Evaluación de la utilización de una consulta de diagnóstico rápido de cáncer de pulmón. Tiempos de demora diagnóstica y terapéutica. Arch Bronconeumol. 2012 Aug;48(8):267–73. Spanish.

  18. Singh H, Hirani K, Kadiyala H, Rudomiotov O, Davis T, Khan MM, et al. Characteristics and predictors of missed opportunities in lung cancer diagnosis: an electronic health record-based study. J Clin Oncol. 2010 Jul 10;28(20):3307–15.

  19. Athey VL, Suckling RJ, Tod AM, Walters SJ, Rogers TK. Early diagnosis of lung cancer: evaluation of a community-based social marketing intervention. Thorax. 2012 May;67(5):412–7.

  20. Álvarez Sintes R, Hernández Cabrera G, Báster Moro JC, Garcia Nuñez RD. Medicina General Integral. Havana: ECIMED; 2008. Spanish.

  21. Salomaa ER, Sällinen S, Hiekkanen H, Liippo K. Delays in the diagnosis and treatment of lung cancer. Chest. 2005 Oct;128(4):2282–8.

  22. Negrín-Villavicencio JA, Soriano-García JL, Rodríguez H, Galego-Pimentel D, Pérez- Caballero MD, Castellanos R, editors. Manual de Prácticas Médicas del Hospital Hermanos Ameijeiras. Unidad Funcional de Tumores. 4th ed. Havana: Editorial Ciencias Médicas; 2012, pp. 886. Spanish.

  23. Clemente MG, Escudero C, Alonso M, Carro F, Cocina B. Demora diagnóstica en el carcinoma broncogénico. Arch Bronconeumol. 2004;20(Suppl 2):1–151. Spanish.

  24. Alberts WM, Bepler G, Hacelton T, Ruckdeschel JC, Williams Jr JH; American College of Chest Physicians. Lung cancer. Practice organization. Chest. 2003 Jan;123(1 Suppl):S332–7.

  25. Hanna SJ, Muneer A, Khalil KH. The 2-week wait for suspected cancer: time for a rethink? Int J Clin Pract. 2005 Nov;59(11):1334–9.

  26. Dodds W, Morgan M, Wolfe C, Raju KS. Implementing the 2-week wait rule for cancer referral in the UK: general practitioners’ views and practices. Eur J Cancer Care (Engl). 2004 Mar;13(1):82–7.

  27. Simunovic M, Gagliardi A, McCreadi D, Coates A, Levine M, DePetrillo D. A snapshot of waiting times for cancer surgery provided by surgeons affi liated with regional cancer centres in Ontario. CMAJ [Internet]. 2001 [cited 2014 Feb 26];165(4). Available from: http://www.cmaj.ca/ content/165/4/421.html

  28. Myrdal G, Lambe M, Hillerdal G, Lamberg K, Agustsson T, Ståhle E. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax. 2004;59:45–9.

  29. Cabanes Varona L, Rodríguez Vázquez JC, Gassiot Nuño CJ, Ramos Quevedo A, Morales Sánchez L, Lima Guerra A. Carcinoma broncógeno: Infl uencia de las demoras diagnósticas y terapéuticas en la supervivencia. Hospital “Hermanos Ameijeiras”. 2003–2009. Neumol Cir Torax. 2011;70(2):84–93. Spanish.

  30. Gagliardi A, Grunfeld E, Evans WK. Evaluation of diagnostic assessment units in oncology: a systematic review. J Clin Oncol. 2004 Mar 15;22(6):1126–35.




2020     |     www.medigraphic.com